nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Discussion on radioactive iodine treatment of hyperthyroidism and the risk of induced cancer
|
Hindié, E. |
|
|
44 |
4 |
p. 287-289 |
artikel |
2 |
Dosimetric methodology for 131I therapy for benign thyroid diseases
|
Piron, B. |
|
|
44 |
4 |
p. 261-266 |
artikel |
3 |
Editorial board
|
|
|
|
44 |
4 |
p. i |
artikel |
4 |
Iodine 131 in the treatment of large goiters
|
Béron, A. |
|
|
44 |
4 |
p. 277-283 |
artikel |
5 |
131I Radioiodine therapy in Graves’ disease: Us et coutumes, controversies and guidelines
|
Bardet, S. |
|
|
44 |
4 |
p. 267-271 |
artikel |
6 |
Management of adenomas and toxic multinodular goiters with Iodine 131
|
Vija Racaru, L. |
|
|
44 |
4 |
p. 272-276 |
artikel |
7 |
Management of hyperthyroid patients following radioactive iodine therapy, with a specific emphasis on Graves’ disease
|
Taïeb, D. |
|
|
44 |
4 |
p. 284-286 |
artikel |
8 |
Quantification of the Thyroid Scan (TS) and correlation to Multiparametric Ultrasounds (MPUS): A textbook case of nuclear molecular imaging
|
Clerc, J. |
|
|
44 |
4 |
p. 216-230 |
artikel |
9 |
Quantified 123I-Thyroid Scan based classification of hyperthyroidism
|
Clerc, J. |
|
|
44 |
4 |
p. 231-249 |
artikel |
10 |
Radioiodine-131 therapy (RIT) in benign thyroid diseases: Personalized prescription based on objectives with optional use of pharmacological modulators
|
Clerc, J. |
|
|
44 |
4 |
p. 250-260 |
artikel |
11 |
Radionuclide imaging and theranostics of benign thyroid diseases
|
Clerc, Jérôme |
|
|
44 |
4 |
p. 213-215 |
artikel |